• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人巨细胞病毒gp55 - 116包膜糖蛋白复合体(gB)的加工过程。

Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.

作者信息

Britt W J, Vugler L G

机构信息

Department of Pediatrics and Microbiology, University of Alabama, Birmingham 35294.

出版信息

J Virol. 1989 Jan;63(1):403-10. doi: 10.1128/JVI.63.1.403-410.1989.

DOI:10.1128/JVI.63.1.403-410.1989
PMID:2535741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC247697/
Abstract

The processing pathway of the major envelope glycoprotein complex, gp55-116 (gB), of human cytomegalovirus was studied using inhibitors of glycosylation and endoglycosidases. The results of these studies indicated that the mature gp55-116 is synthesized by the addition of both simple and complex N-linked sugars to a nonglycosylated precursor of estimated Mr 105,000. In a rapid processing step, the Mr 105,000 precursor is glycosylated to a protein of Mr 150,000 (gp150) which contains only endoglycosidase H-sensitive sugar linkages. The gp150 is then processed relatively slowly to a Mr 165,000 to 170,000 species (gp165-170), which is then cleaved to yield the mature gp55-116. Monensin prevented the final processing steps of the gp150, including cleavage, suggesting that transport through the Golgi apparatus is required for complete processing. Digestion of the intracellular forms of this complex as well as the virion forms confirmed the above findings and indicated that the mature virion form of gp55 contains 8,000 daltons of N-linked sugars. The virion gp116 contains some 52,000 to 57,000 daltons of N-linked carbohydrates and approximately 5,000 daltons of O-linked sugars.

摘要

利用糖基化抑制剂和内切糖苷酶研究了人巨细胞病毒主要包膜糖蛋白复合物gp55 - 116(gB)的加工途径。这些研究结果表明,成熟的gp55 - 116是通过将简单型和复合型N - 连接糖添加到估计分子量为105,000的非糖基化前体上合成的。在一个快速加工步骤中,分子量为105,000的前体被糖基化为分子量为150,000的蛋白质(gp150),该蛋白质仅含有对内切糖苷酶H敏感的糖连接。然后,gp150相对缓慢地加工为分子量为165,000至170,000的物质(gp165 - 170),随后被切割产生成熟的gp55 - 116。莫能菌素阻止了gp150的最终加工步骤,包括切割,这表明通过高尔基体的运输是完全加工所必需的。对该复合物的细胞内形式以及病毒体形式的消化证实了上述发现,并表明gp55的成熟病毒体形式含有8,000道尔顿的N - 连接糖。病毒体gp116含有约52,000至57,000道尔顿的N - 连接碳水化合物和约5,000道尔顿的O - 连接糖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/54fce6ab8a89/jvirol00068-0425-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/b49241014669/jvirol00068-0422-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/ee7e4a5c9892/jvirol00068-0423-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/6a47dc4864ba/jvirol00068-0423-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/b3e1ec9c6cd3/jvirol00068-0424-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/8838015e073e/jvirol00068-0424-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/19296316f143/jvirol00068-0425-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/b82ede9ba4b1/jvirol00068-0425-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/54fce6ab8a89/jvirol00068-0425-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/b49241014669/jvirol00068-0422-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/ee7e4a5c9892/jvirol00068-0423-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/6a47dc4864ba/jvirol00068-0423-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/b3e1ec9c6cd3/jvirol00068-0424-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/8838015e073e/jvirol00068-0424-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/19296316f143/jvirol00068-0425-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/b82ede9ba4b1/jvirol00068-0425-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299d/247697/54fce6ab8a89/jvirol00068-0425-c.jpg

相似文献

1
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.人巨细胞病毒gp55 - 116包膜糖蛋白复合体(gB)的加工过程。
J Virol. 1989 Jan;63(1):403-10. doi: 10.1128/JVI.63.1.403-410.1989.
2
Characterization of a human cytomegalovirus glycoprotein complex (gcI).
J Gen Virol. 1988 Jun;69 ( Pt 6):1205-15. doi: 10.1099/0022-1317-69-6-1205.
3
Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus.
Virology. 1991 Jan;180(1):239-50. doi: 10.1016/0042-6822(91)90028-a.
4
Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.人巨细胞病毒包膜糖蛋白55-116复合物的合成与加工
J Virol. 1986 Apr;58(1):185-91. doi: 10.1128/JVI.58.1.185-191.1986.
5
Processing of human cytomegalovirus glycoprotein B in recombinant adenovirus-infected cells.
J Gen Virol. 1996 Jul;77 ( Pt 7):1549-57. doi: 10.1099/0022-1317-77-7-1549.
6
Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor.大鼠C6神经胶质细胞中胰岛素样生长因子-II(IGF-II)/甘露糖-6-磷酸受体的生物合成:N-连接糖基化在IGF-II与受体结合中的作用。
Mol Endocrinol. 1991 Feb;5(2):281-91. doi: 10.1210/mend-5-2-281.
7
Intracellular formation and processing of the heterotrimeric gH-gL-gO (gCIII) glycoprotein envelope complex of human cytomegalovirus.人巨细胞病毒异源三聚体gH-gL-gO(gCIII)糖蛋白包膜复合物的细胞内形成与加工
J Virol. 1999 May;73(5):3886-92. doi: 10.1128/JVI.73.5.3886-3892.1999.
8
Nuclear compartmentation of glycoprotein B of human cytomegalovirus.人巨细胞病毒糖蛋白B的核区室化
Virology. 1990 Aug;177(2):515-22. doi: 10.1016/0042-6822(90)90516-t.
9
Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.钙联蛋白在人巨细胞病毒糖蛋白B折叠过程中充当分子伴侣。
J Virol. 1996 Apr;70(4):2237-46. doi: 10.1128/JVI.70.4.2237-2246.1996.
10
Characterization of glycoprotein B of the gammaherpesvirus equine herpesvirus-2.γ-疱疹病毒马疱疹病毒2型糖蛋白B的特性分析
J Gen Virol. 1998 Jul;79 ( Pt 7):1619-29. doi: 10.1099/0022-1317-79-7-1619.

引用本文的文献

1
Human cytomegalovirus promotes PC synthesis during early virus replication.人巨细胞病毒在病毒早期复制过程中促进磷脂酰胆碱的合成。
J Virol. 2025 Aug 19:e0057925. doi: 10.1128/jvi.00579-25.
2
Glucose-independent human cytomegalovirus replication is supported by metabolites that feed upper glycolytic branches.葡萄糖非依赖性人巨细胞病毒复制由代谢物支持,这些代谢物为糖酵解上游分支提供营养。
Proc Natl Acad Sci U S A. 2024 Nov 26;121(48):e2412966121. doi: 10.1073/pnas.2412966121. Epub 2024 Nov 19.
3
Analysis and Fine Specificity of the HCMV-Specific Cell-Free and Cell-Associated Antibody-Dependent Cellular Phagocytosis (ADCP) Responses in Lung Transplant Recipients.

本文引用的文献

1
Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus.中和抗体可检测到人巨细胞病毒包膜内一种二硫键连接的糖蛋白复合物。
Virology. 1984 Jun;135(2):369-78. doi: 10.1016/0042-6822(84)90193-4.
2
Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins.针对人巨细胞病毒病毒体蛋白的单克隆抗体和多克隆免疫血清的特性分析
Virology. 1984 Jan 30;132(2):325-38. doi: 10.1016/0042-6822(84)90039-4.
3
Glycosylation pathways of two major Epstein-Barr virus membrane antigens.
肺移植受者中巨细胞病毒特异性游离和细胞相关抗体依赖的细胞吞噬(ADCP)反应的分析及精细特异性。
Int J Mol Sci. 2021 Jul 30;22(15):8206. doi: 10.3390/ijms22158206.
4
Exploring the N-Glycosylation Profile of Glycoprotein B from Human Cytomegalovirus Expressed in CHO and BY-2 Cells.探讨在 CHO 和 BY-2 细胞中表达的人巨细胞病毒糖蛋白 B 的 N-糖基化谱。
Int J Mol Sci. 2019 Jul 31;20(15):3741. doi: 10.3390/ijms20153741.
5
Development of novel vaccines against human cytomegalovirus.新型人巨细胞病毒疫苗的研制。
Hum Vaccin Immunother. 2019;15(11):2673-2683. doi: 10.1080/21645515.2019.1593729. Epub 2019 Apr 24.
6
Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response.新型三聚体人巨细胞病毒糖蛋白 B 引发高滴度中和抗体反应。
Vaccine. 2018 Sep 5;36(37):5580-5590. doi: 10.1016/j.vaccine.2018.07.056. Epub 2018 Aug 3.
7
Global aspects of viral glycosylation.病毒糖基化的全球方面。
Glycobiology. 2018 Jul 1;28(7):443-467. doi: 10.1093/glycob/cwy021.
8
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination.补体增强了针对人巨细胞病毒糖蛋白B(gB)的抗体以及gB/MF59疫苗诱导的免疫血清的体外中和效力。
NPJ Vaccines. 2017 Dec 14;2:36. doi: 10.1038/s41541-017-0038-0. eCollection 2017.
9
Positively Selected Sites at HCMV gB Furin Processing Region and Their Effects in Cleavage Efficiency.人巨细胞病毒糖蛋白B弗林蛋白酶切割区域的正选择位点及其对切割效率的影响。
Front Microbiol. 2017 May 23;8:934. doi: 10.3389/fmicb.2017.00934. eCollection 2017.
10
Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.人巨细胞病毒的病毒粒子糖蛋白介导的免疫逃逸:一种黏病毒巧妙逃脱
Microbiol Mol Biol Rev. 2016 Jun 15;80(3):663-77. doi: 10.1128/MMBR.00018-16. Print 2016 Sep.
两种主要的爱泼斯坦-巴尔病毒膜抗原的糖基化途径。
Virology. 1983 May;127(1):168-76. doi: 10.1016/0042-6822(83)90381-1.
4
O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus.O-连接寡糖由单纯疱疹病毒糖蛋白在高尔基体中获得。
Cell. 1983 Mar;32(3):987-97. doi: 10.1016/0092-8674(83)90083-1.
5
Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells.莫能菌素抑制单纯疱疹病毒糖蛋白的加工、其向细胞表面的转运以及病毒粒子从受感染细胞中的释放。
J Virol. 1982 Sep;43(3):1102-12. doi: 10.1128/JVI.43.3.1102-1112.1982.
6
Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies.用单克隆抗体鉴定人巨细胞病毒糖蛋白的多态性。
Virology. 1984 Nov;139(1):73-86. doi: 10.1016/0042-6822(84)90331-3.
7
Characterization of the human cytomegalovirus envelope glycoproteins.人巨细胞病毒包膜糖蛋白的特性分析。
J Gen Virol. 1984 Nov;65 ( Pt 11):1991-2001. doi: 10.1099/0022-1317-65-11-1991.
8
Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.人巨细胞病毒糖蛋白B基因的鉴定及其在重组痘苗病毒中的表达诱导中和抗体
EMBO J. 1986 Nov;5(11):3057-63. doi: 10.1002/j.1460-2075.1986.tb04606.x.
9
Primate cytomegalovirus glycoproteins: lectin-binding properties and sensitivities to glycosidases.灵长类巨细胞病毒糖蛋白:凝集素结合特性及对糖苷酶的敏感性
J Virol. 1986 Sep;59(3):703-13. doi: 10.1128/JVI.59.3.703-713.1986.
10
Human cytomegalovirus virion-associated protein with kinase activity.具有激酶活性的人巨细胞病毒病毒体相关蛋白。
J Virol. 1986 Jul;59(1):185-8. doi: 10.1128/JVI.59.1.185-188.1986.